4.4 Article

Glutathione, N-acetylcysteine and Lipoic Acid Down-Regulate Starvation-Induced Apoptosis, RANKL/OPG Ratio and Sclerostin in Osteocytes: Involvement of JNK and ERK1/2 Signalling

Journal

CALCIFIED TISSUE INTERNATIONAL
Volume 96, Issue 4, Pages 335-346

Publisher

SPRINGER
DOI: 10.1007/s00223-015-9961-0

Keywords

Osteocytes; Antioxidants; Apoptosis; Bone remodelling

Funding

  1. Ministero dell'Istruzione, dell'Universita e della Ricerca
  2. Fondazione Cassa di Risparmio di Firenze

Ask authors/readers for more resources

Osteocyte apoptosis due to microdamage and/or oxidative stress is related to increased local bone turnover and resorption observed in various bone diseases. Previous data on osteoblasts and osteoclasts have linked reactive oxygen species and antioxidants to bone remodelling. This study performs a comprehensive analysis on the effect of antioxidants such as glutathione (GSH), N-acetylcysteine and lipoic acid (LA) on starvation-induced osteocyte apoptosis and on cytokines involved in bone remodelling such as the receptor activator kB ligand (RANKL), osteoprotegerin (OPG) and sclerostin. For this study, apoptosis was induced by serum starvation in a murine osteocyte-like cell line MLO-Y4; this condition mimics in part osteocyte apoptosis due to microdamage. The results show that starvation-induced apoptosis and expression of RANKL, OPG and sclerostin are redox regulated processes. All antioxidants are able to inhibit the apoptosis due to starvation. They down-regulate the expression and the release of RANKL, the expression of sclerostin and RANKL/OPG ratio, whereas they only in part up-regulate OPG expression. Antioxidants mediate their effect on starvation-induced apoptosis by JNK signalling and on cytokine expression by both JNK and ERK1/2 activities. This study shows the possible involvement of biological antioxidants such as GSH and LA on redox regulated mechanisms related to apoptosis and expression of cytokines involved in bone remodelling. Moreover, it suggests that both JNK and ERK1/2 may be useful biological targets for drugs affecting bone diseases associated with increased oxidative stress.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.4
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

Article Endocrinology & Metabolism

Aberrant Epigenetic Alteration of PAX1 Expression Contributes to Parathyroid Tumorigenesis

Priyanka Singh, Sanjay Kumar Bhadada, Ashutosh Kumar Arya, Uma Nahar Saikia, Naresh Sachdeva, Divya Dahiya, Jyotdeep Kaur, Maria Luisa Brandi, Sudhaker Dhanwada Rao

Summary: This study investigated the epigenetic-mediated mechanism of the PAX1 gene in sporadic parathyroid adenomas. The results revealed that the expression of PAX1 was significantly reduced in parathyroid adenomas, which was associated with hypermethylation in the promoter region and lower levels of histone modification. Treatment with a pharmacologic inhibitor led to the re-expression of the PAX1 gene. These findings provide insights into the epigenetic deregulation of PAX1 in parathyroid adenomas and have potential clinical and therapeutic implications for patients with PHPT.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Article Biochemistry & Molecular Biology

Effect of Oxidative Stress-Induced Apoptosis on Active FGF23 Levels in MLO-Y4 Cells: The Protective Role of 17-β-Estradiol

Vladana Domazetovic, Irene Falsetti, Simone Ciuffi, Teresa Iantomasi, Gemma Marcucci, Maria Teresa Vincenzini, Maria Luisa Brandi

Summary: The present study investigates the cellular and molecular mechanisms involved in the control of FGF23 production and bone remodeling functions. The results demonstrate a relationship between oxidative stress-induced apoptosis and up-regulation of active FGF23 levels, as well as the impact of 17 beta-estradiol in preventing FGF23 increase. These findings identify potential therapeutic targets for oxidative stress-related bone and non-bone inflammatory diseases.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2022)

Article Endocrinology & Metabolism

ALPL Genotypes in Patients With Atypical Femur Fractures or Other Biochemical and Clinical Signs of Hypophosphatasia

Francesca Marini, Laura Masi, Francesca Giusti, Luisella Cianferotti, Federica Cioppi, Gemma Marcucci, Simone Ciuffi, Emmanuel Biver, Giuseppe Toro, Giovanni Iolascon, Teresa Iantomasi, Maria Luisa Brandi

Summary: This study aimed to perform ALPL genetic testing to identify rare variants in suspected adult patients with hypophosphatasia (HPP). The analysis compared the frequencies of ALPL common variants in individuals with biochemical and/or clinical signs suggestive of adult HPP and non-HPP controls, as well as among different clinical subgroups of patients with a clinical suspicion of adult HPP.

JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2022)

Review Nutrition & Dietetics

Time for Revival of Bone Biopsy with Histomorphometric Analysis in Chronic Kidney Disease (CKD): Moving from Skepticism to Pragmatism

Maria Fusaro, Giulia Vanessa Re Sarto, Maurizio Gallieni, Laura Cosmai, Piergiorgio Messa, Maurizio Rossini, Iacopo Chiodini, Mario Plebani, Pieter Evenepoel, Nicholas Harvey, Serge Ferrari, Jorge Cannata-Andia, Andrea Trombetti, Maria Luisa Brandi, Markus Ketteler, Thomas L. Nickolas, John Cunningham, Syazrah Salam, Carlo Della Rocca, Aldo Scarpa, Salvatore Minisola, Fabio Malberti, Filomena Cetani, Mario Cozzolino, Sandro Mazzaferro, Luigi Morrone, Giovanni Tripepi, Martina Zaninotto, Maria Cristina Mereu, Maura Ravera, Giuseppe Cianciolo, Gaetano La Manna, Andrea Aghi, Sandro Giannini, Luca Dalle Carbonare

Summary: Bone biopsy with histomorphometric analysis is the gold standard for diagnosing and classifying renal osteodystrophy. However, its use has declined due to various reasons. This position paper from Italian scientific societies aims to promote the use of bone biopsy and improve the management and prognosis of CKD patients through optimization and standardization of the procedure, establishment of a network, and reimbursement adjustments.

NUTRIENTS (2022)

Article Endocrinology & Metabolism

Multicenter retro-prospective observational study on chronic hypoparathyroidism and rhPTH (1-84) treatment

G. Marcucci, G. Beccuti, G. Carosi, F. Cetani, L. Cianferotti, A. M. Colao, C. Di Somma, M. Duradoni, A. Elefante, L. Ghizzoni, M. Giusti, A. G. Lania, E. Lavezzi, B. Madeo, G. Mantovani, C. Marcocci, L. Masi, S. Parri, F. Pigliaru, A. Santonati, A. Spada, L. Vera, M. L. Brandi

Summary: This study investigates the effects of 12 months of rhPTH (1-84) treatment in patients with hypoparathyroidism. The results show that rhPTH (1-84) therapy is both safe and effective.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2022)

Review Endocrinology & Metabolism

Genetics and Epigenetics of Parathyroid Carcinoma

Francesca Marini, Francesca Giusti, Gaia Palmini, Giuliano Perigli, Roberto Santoro, Maria Luisa Brandi

Summary: Parathyroid carcinoma is an extremely rare malignancy associated with hypercalcemia and excessive secretion of parathyroid hormone. There are currently no effective therapies available for this cancer. Understanding the genetic and molecular pathways involved in the development of parathyroid carcinoma is crucial for distinguishing malignant and benign tumors, as well as identifying potential targets for novel therapies.

FRONTIERS IN ENDOCRINOLOGY (2022)

Review Biochemistry & Molecular Biology

Oxidative Stress and Natural Antioxidants in Osteoporosis: Novel Preventive and Therapeutic Approaches

Gemma Marcucci, Vladana Domazetovic, Chiara Nediani, Jessica Ruzzolini, Claudio Favre, Maria Luisa Brandi

Summary: This review provides a detailed report on the cellular and molecular mechanisms involved in bone remodeling, specifically in relation to oxidative stress, inflammatory factors, and estrogen deficiency. Oxidative stress is a key factor in the development of osteoporosis, leading to osteocyte apoptosis and impaired bone remodeling and resorption. Recent studies have shown that natural antioxidants found in the diet can effectively prevent and reduce the negative effects of oxidative stress on bone health. These antioxidants target osteocytes and their molecular factors, promoting bone regeneration and preventing bone loss. This suggests that incorporating antioxidants into therapeutic approaches may improve the prevention and treatment of osteoporosis and related bone diseases.

ANTIOXIDANTS (2023)

Article Genetics & Heredity

Role of the Vitamin D Receptor (VDR) in the Pathogenesis of Osteoporosis: A Genetic, Epigenetic and Molecular Pilot Study

Beatrice Gasperini, Virginia Veronica Visconti, Cinzia Ciccacci, Angela Falvino, Elena Gasbarra, Riccardo Iundusi, Maria Luisa Brandi, Annalisa Botta, Umberto Tarantino

Summary: This study aimed to explore the association between genetic variability, expression, and methylation pattern of the vitamin D receptor (VDR) with the risk of osteoporosis (OP) in a cohort of Caucasian patients. The results showed a significant association between the Cdx2 rs11568820 polymorphism and OP risk. Additionally, the VDR transcriptomic profile suggests a potential interconnection with OP progression, providing a useful tool for stratifying OP phenotype and fragility fracture risk.

GENES (2023)

Article Biochemistry & Molecular Biology

In Vitro Effects of PTH (1-84) on Human Skeletal Muscle-Derived Satellite Cells

Cecilia Romagnoli, Roberto Zonefrati, Elena Lucattelli, Marco Innocenti, Roberto Civinini, Teresa Iantomasi, Maria Luisa Brandi

Summary: This study evaluated the effects of PTH on the proliferation and differentiation of skeletal muscle satellite cells isolated from human biopsies. Results showed no significant changes in cAMP and proliferation in the isolated cells treated with PTH, but differentiated myotubes treated with PTH exhibited increased cAMP, expression of myogenic differentiation genes, and MHC protein. This study provides new insights into the effects of PTH on human skeletal muscle cells and opens new avenues for research in muscle pathophysiology.

BIOMEDICINES (2023)

Review Chemistry, Medicinal

Calcifediol: Why, When, How Much?

Simone Donati, Francesca Marini, Francesca Giusti, Gaia Palmini, Cinzia Aurilia, Irene Falsetti, Teresa Iantomasi, Maria Luisa Brandi

Summary: Vitamin D deficiency is a global health problem with negative consequences on musculoskeletal and extra-skeletal health. Increasing intake of vitamin D fortified foods and administering vitamin D supplementation, such as vitamin D3 or calcifediol, can help improve vitamin D status. This review discusses the potential medical benefits and specific clinical scenarios in which oral intake of calcifediol could be effective in restoring optimal serum levels of 25(OH)D3. Insights into calcifediol-related non-genomic responses are provided, suggesting its use as a supplement for individuals at higher risk of hypovitaminosis D.

PHARMACEUTICALS (2023)

Review Nutrition & Dietetics

Calcifediol: Mechanisms of Action

Simone Donati, Gaia Palmini, Cinzia Aurilia, Irene Falsetti, Francesca Marini, Francesca Giusti, Teresa Iantomasi, Maria Luisa Brandi

Summary: Calcitriol, the active form of vitamin D, plays a crucial role in calcium and phosphate regulation. It functions through both genomic and non-genomic mechanisms. The traditional function involves binding to the vitamin D receptor (VDR) and influencing gene transcription, while non-genomic effects occur rapidly through interactions with specific membrane receptors. Calcifediol, the precursor metabolite of calcitriol, has also been found to have gene-regulatory properties and can trigger non-genomic responses.

NUTRIENTS (2023)

Article Oncology

Pancreatic Neuroendocrine Tumors in MEN1 Patients: Difference in Post-Operative Complications and Tumor Progression between Major and Minimal Pancreatic Surgeries

Francesco Tonelli, Francesca Marini, Francesca Giusti, Teresa Iantomasi, Francesco Giudici, Maria Luisa Brandi

Summary: In this study, we described the post-operative complications, pancreatic sequelae, and post-surgical progression/relapse of PNENs in MEN1 patients. Our results showed that a more conservative intervention was associated with the absence of post-surgical complications, but required further pancreas surgeries for tumor relapse in 40.0% of the operated cases.

CANCERS (2023)

Meeting Abstract Geriatrics & Gerontology

PARATHYROID CARCINOMA: INSTITUTION OF AN ITALIAN MULTICENTER PATIENT DATABASE

F. Miglietta, F. Marini, F. Giusti, G. Palmini, G. Perigli, P. Lolli, S. Corbetta, M. V. Davi, L. Persani, C. Eller-Vainicher, S. Benvenga, D. Ferone, V. Camozzi, E. Arvat, R. M. Ruggieri, U. Pagotto, M. Iacobone, M. C. Zatelli, G. Marcucci, M. L. Brandi

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Review Geriatrics & Gerontology

Management of patients at very high risk of osteoporotic fractures through sequential treatments

Elizabeth M. Curtis, Jean-Yves Reginster, Nasser Al-Daghri, Emmanuel Biver, Maria Luisa Brandi, Etienne Cavalier, Peyman Hadji, Philippe Halbout, Nicholas C. Harvey, Mickael Hiligsmann, M. Kassim Javaid, John A. Kanis, Jean-Marc Kaufman, Olivier Lamy, Radmila Matijevic, Adolfo Diez Perez, Regis Pierre Radermecker, Mario Miguel Rosa, Thierry Thomas, Friederike Thomasius, Mila Vlaskovska, Rene Rizzoli, Cyrus Cooper

Summary: Osteoporosis care has evolved significantly, with established clinical definitions, validated fracture risk assessment methods, and effective pharmacological agents. Anabolic agents have shown to be more rapid and efficacious in reducing fracture risk compared to antiresorptive therapies. Expert recommendations support an initial intervention with anabolic agents for high-risk fracture patients, followed by maintenance therapy using antiresorptive agents and long-term osteoporosis treatment.

AGING CLINICAL AND EXPERIMENTAL RESEARCH (2022)

Review Endocrinology & Metabolism

Persistence and recurrence in tumor-induced osteomalacia: A systematic review of the literature and results from a national survey/case series

Luisella Cianferotti, Chiara Delli Poggi, Francesco Bertoldo, Carla Caffarelli, Chiara Crotti, Davide Gatti, Sandro Giannini, Stefano Gonnelli, Maurizio Mazzantini, Viapiana Ombretta, Stefania Sella, Angela Setti, Massimo Varenna, Francesca Zucchi, Maria Luisa Brandi

Summary: Tumor-induced osteomalacia is a rare mineral metabolism disorder characterized by hypophosphatemia. This study found that a significant number of TIO patients remain undiagnosed or persist after surgery, making them potential candidates for burosumab treatment.

ENDOCRINE (2022)

No Data Available